AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Adhera Therapeutics Inc

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0.01
Market Cap
722
AVG Volume
124
Trailing/Forward PE
-0/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
00.250.50.75121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
23 Q30
23 Q20
23 Q10
22 Q40
22 Q30
22 Q20
22 Q10
21 Q40
21 Q30
21 Q20
Net Income (USD) · TTM
-8M-6M-4M-2M021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
23 Q3-4.49M
23 Q2-2.75M
23 Q1-2.92M
22 Q4-2.11M
22 Q3-3.45M
22 Q2-5.38M
22 Q1-6M
21 Q4-6.35M
21 Q3-5.16M
21 Q2-1.96M
Operating Income (USD) · TTM
-2M-1.5M-1M-500K021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
23 Q3-1.28M
23 Q2-1.56M
23 Q1-1.71M
22 Q4-1.62M
22 Q3-1.46M
22 Q2-1.14M
22 Q1-824K
21 Q4-674K
21 Q3-635K
21 Q2-597K
EBITDA (USD) · TTM
-6M-4M-2M02M4M21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
23 Q31.01M
23 Q23.51M
23 Q13.42M
22 Q43.33M
22 Q3695.57K
22 Q2-2.29M
22 Q1-3.6M
21 Q4-4.38M
21 Q3-3.49M
21 Q2-509K
Cash Flows (USD) · TTM
-2M-1.5M-1M-500K021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
23 Q3-808.15K
23 Q2-1.35M
23 Q1-1.51M
22 Q4-1.42M
22 Q3-1.56M
22 Q2-1.24M
22 Q1-835K
21 Q4-665K
21 Q3-459K
21 Q2-216K
EPS (USD) · TTM
-15-10-5021 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
23 Q3-0.62
23 Q2-0.36
23 Q1-0.62
22 Q4-0.84
22 Q3-1.48
22 Q2-6.67
22 Q1-8
21 Q4-9.89
21 Q3-10.65
21 Q2-6.69
Expenses (USD) · TTM
0500K1M1.5M2MR&DSG&ACapex21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
23 Q31.28M
23 Q21.56M
23 Q11.71M
22 Q41.62M
22 Q31.46M
22 Q21.14M
22 Q1824K
21 Q4674K
21 Q3635K
21 Q2597K
Shares Outstanding (USD) · TTM
02.5K5K7.5K10KBuybacks (Repurchases)Stock-Based Compensation21 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q223 Q3
ATRX Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
23 Q32K
23 Q22K
23 Q14K
22 Q44K
22 Q32K
22 Q22K
22 Q10
21 Q40
21 Q38K
21 Q210K
Employee Count
01020302011201220132014201520162017201820192022
ATRX Employee Count by quarter
PeriodEmployee Count
20221
20192
201824
20177
20164
20151
20141
201311
201211
201111
PE Ratio
0204060med 2.49Jul 15Jan 16Apr 16Jul 16Oct 16Dec 16Mar 17
ATRX PE Ratio by quarter
PeriodPE Ratio
Mar 1750.9
Mar 1746.74
Mar 1747.8
Mar 1755.24
Feb 1748.86
Feb 1737.18
Feb 1738.03
Feb 1730.55
Jan 1730.38
Jan 1733.3
Jan 1736.08
Jan 1737.16
Dec 1631.87
Dec 1629.74
Dec 1640.36
Dec 1632.93
Dec 1640.36
Nov 1626.56
Nov 162.49
Nov 162.49
Nov 162.24
Oct 162.48
Oct 162.49
Oct 162.99
Oct 163.14
Sep 163.24
Sep 163.74
Sep 163.17
Sep 163.24
Sep 163.12
Aug 163.61
Aug 163.24
Aug 161.18
Aug 161.05
Jul 161.23
Jul 161.2
Jul 161.47
Jul 161.27
Jul 161.09
Jun 161.31
Jun 161.31
Jun 161.47
Jun 161.88
May 162.29
May 162.19
May 161.83
May 162.17
Apr 161.54
Apr 161.42
Apr 161.57
Apr 161.62
Apr 161.37
Mar 160.43
Mar 160.46
Mar 160.48
Mar 160.52
Feb 160.56
Feb 160.46
Feb 160.56
Feb 160.49
Jan 160.5
Jan 160.56
Jan 160.62
Jan 160.65
Dec 150.82
Dec 150.89
Dec 150.86
Dec 150.85
Dec 151.08
Nov 150.84
Nov 150.85
Aug 153.82
Jul 153.31
Jul 153.83
Jul 154.59
Jul 153.58
Jul 154
Jun 154.26
Jun 154.51
Jun 153.7
Jun 153.57
May 154
May 154.42
May 154.55
Free Cash Flow Yield
-200000%-150000%-100000%-50000%0%med -187768.36%Jan 25May 25Sep 25Jan 26May 26Sep 26
ATRX Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-187768.36%
Sep 26-187768.36%
Aug 26-187768.36%
Aug 26-187768.36%
Aug 26-187768.36%
Aug 26-187768.36%
Jul 26-187768.36%
Jul 26-187768.36%
Jul 26-187768.36%
Jul 26-187768.36%
Jul 26-187768.36%
Jun 26-187768.36%
Jun 26-187768.36%
Jun 26-187768.36%
Jun 26-187768.36%
May 26-187768.36%
May 26-187768.36%
May 26-187768.36%
May 26-187768.36%
May 26-187768.36%
Apr 26-187768.36%
Apr 26-187768.36%
Apr 26-187768.36%
Apr 26-187768.36%
Mar 26-187768.36%
Mar 26-187768.36%
Mar 26-187768.36%
Mar 26-187768.36%
Feb 26-187768.36%
Feb 26-187768.36%
Feb 26-187768.36%
Feb 26-187768.36%
Jan 26-187768.36%
Jan 26-187768.36%
Jan 26-187768.36%
Jan 26-187768.36%
Jan 26-187768.36%
Dec 25-187768.36%
Dec 25-187768.36%
Dec 25-187768.36%
Dec 25-187768.36%
Nov 25-187768.36%
Nov 25-187768.36%
Nov 25-187768.36%
Nov 25-187768.36%
Oct 25-187768.36%
Oct 25-187768.36%
Oct 25-187768.36%
Oct 25-187768.36%
Oct 25-1877.68%
Sep 25-1877.68%
Sep 25-1877.68%
Sep 25-1877.68%
Sep 25-1877.68%
Aug 25-1877.68%
Aug 25-1877.68%
Aug 25-1877.68%
Aug 25-187768.36%
Aug 25-187768.36%
Jul 25-187768.36%
Jul 25-187768.36%
Jul 25-187768.36%
Jul 25-187768.36%
Jun 25-187768.36%
Jun 25-187768.36%
Jun 25-187768.36%
Jun 25-187768.36%
May 25-187768.36%
May 25-187768.36%
May 25-187768.36%
May 25-187768.36%
May 25-187768.36%
Apr 25-187768.36%
Apr 25-187768.36%
Apr 25-187768.36%
Apr 25-187768.36%
Mar 25-187768.36%
Mar 25-187768.36%
Mar 25-187768.36%
Mar 25-187768.36%
Feb 25-187768.36%
Feb 25-187768.36%
Feb 25-187768.36%
Feb 25-187768.36%
Jan 25-187768.36%
Jan 25-187768.36%
Jan 25-187768.36%
Jan 25-187768.36%
Jan 25-187768.36%
Dec 24-187768.36%
Dec 24-93884.18%
Dec 24-7823.68%
Dec 24-7823.68%
Nov 24-7823.68%
Nov 24-7823.68%
Nov 24-7823.68%
Nov 24-93884.18%
Nov 24-93884.18%
Oct 24-93884.18%
Oct 24-7823.68%
Price to Sales
010203040med 4.77Jul 19Oct 19Feb 20May 20Sep 20Dec 20Apr 21
ATRX Price to Sales by quarter
PeriodPrice to Sales
Apr 217
Mar 217.41
Mar 217.41
Mar 219.06
Mar 219.88
Feb 2110.38
Feb 217.16
Feb 219.06
Feb 217.66
Jan 217.04
Jan 215.52
Jan 214.12
Jan 214.16
Dec 203.42
Dec 203.87
Dec 204.94
Dec 205.27
Dec 204.61
Nov 206.59
Nov 204.78
Nov 203.27
Nov 203.56
Oct 204.66
Oct 204.16
Oct 203.86
Oct 203.27
Oct 202.68
Sep 203.5
Sep 204.04
Sep 202.86
Sep 202.75
Aug 204.51
Aug 205.58
Aug 204.23
Aug 203.82
Jul 203.38
Jul 202.58
Jul 202.79
Jul 202.68
Jul 203.01
Jun 203.87
Jun 203.87
Jun 203.44
Jun 201.98
May 201.94
May 201.94
May 201.94
May 201.66
May 201.72
Apr 201.51
Apr 201.72
Apr 202.72
Apr 203.63
Mar 204.08
Mar 204.13
Mar 204.26
Mar 205.44
Feb 204.08
Feb 206.26
Feb 204.54
Feb 204.85
Jan 206.58
Jan 206.4
Jan 205.99
Jan 204.76
Jan 204.63
Dec 194.54
Dec 195.9
Dec 194.25
Dec 193.63
Nov 194.54
Nov 193.72
Nov 193.59
Nov 195.47
Nov 196.74
Oct 196.74
Oct 197.11
Oct 197.11
Oct 197.11
Sep 196.37
Sep 195.24
Sep 195.99
Sep 198.99
Aug 1910.04
Aug 1910.48
Aug 1913.48
Aug 1921.83
Aug 1922.52
Jul 1921.15
Jul 1923.88
Jul 1920.47
Jul 1920.47
Jun 1921.83
Jun 1924.56
Jun 1924.56
Jun 1927.29
May 1927.29
May 1933.98
May 1934.12
May 1938.17
EV/EBITDA
10.6610.6810.710.72med 10.66Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
ATRX EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2610.66
Sep 2610.66
Aug 2610.66
Aug 2610.66
Aug 2610.66
Aug 2610.66
Jul 2610.66
Jul 2610.66
Jul 2610.66
Jul 2610.66
Jul 2610.66
Jun 2610.66
Jun 2610.66
Jun 2610.66
Jun 2610.66
May 2610.66
May 2610.66
May 2610.66
May 2610.66
May 2610.66
Apr 2610.66
Apr 2610.66
Apr 2610.66
Apr 2610.66
Mar 2610.66
Mar 2610.66
Mar 2610.66
Mar 2610.66
Feb 2610.66
Feb 2610.66
Feb 2610.66
Feb 2610.66
Jan 2610.66
Jan 2610.66
Jan 2610.66
Jan 2610.66
Jan 2610.66
Dec 2510.66
Dec 2510.66
Dec 2510.66
Dec 2510.66
Nov 2510.66
Nov 2510.66
Nov 2510.66
Nov 2510.66
Oct 2510.66
Oct 2510.66
Oct 2510.66
Oct 2510.66
Oct 2510.71
Sep 2510.71
Sep 2510.71
Sep 2510.71
Sep 2510.71
Aug 2510.71
Aug 2510.71
Aug 2510.71
Aug 2510.66
Aug 2510.66
Jul 2510.66
Jul 2510.66
Jul 2510.66
Jul 2510.66
Jun 2510.66
Jun 2510.66
Jun 2510.66
Jun 2510.66
May 2510.66
May 2510.66
May 2510.66
May 2510.66
May 2510.66
Apr 2510.66
Apr 2510.66
Apr 2510.66
Apr 2510.66
Mar 2510.66
Mar 2510.66
Mar 2510.66
Mar 2510.66
Feb 2510.66
Feb 2510.66
Feb 2510.66
Feb 2510.66
Jan 2510.66
Jan 2510.66
Jan 2510.66
Jan 2510.66
Jan 2510.66
Dec 2410.66
Dec 2410.66
Dec 2410.67
Dec 2410.67
Nov 2410.67
Nov 2410.67
Nov 2410.67
Nov 2410.66
Nov 2410.66
Oct 2410.66
Oct 2410.67
Price/Operating Cashflow
3435363738Aug 14Aug 14
ATRX Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Aug 1437.44
Aug 1434.17
Price to Book
0102030med 5.64Aug 17Dec 17Mar 18Sep 18Jan 19Apr 19Aug 19
ATRX Price to Book by quarter
PeriodPrice to Book
Aug 194.51
Aug 194.65
Jul 194.37
Jul 194.94
Jul 194.23
Jul 194.23
Jun 194.51
Jun 195.08
Jun 195.08
Jun 195.64
May 195.64
May 197.02
May 197.05
May 190.99
May 191.03
Apr 191.29
Apr 191.32
Apr 190.66
Apr 190.68
Mar 190.74
Mar 190.74
Mar 190.64
Mar 190.66
Mar 190.72
Feb 190.66
Feb 190.64
Feb 190.63
Feb 190.69
Jan 190.62
Jan 190.61
Jan 190.48
Jan 190.61
Dec 180.48
Dec 180.54
Dec 180.57
Dec 180.55
Nov 180.66
Nov 180.65
Nov 180.31
Nov 180.31
Nov 180.36
Oct 180.4
Oct 180.42
Oct 180.37
Oct 180.38
Sep 180.48
Sep 180.49
Sep 180.52
Sep 180.49
Aug 180.52
Aug 180.57
Aug 180.6
Aug 180.54
May 1819.75
May 1822.6
Apr 1819.31
Apr 1822.16
Apr 187.26
Apr 188.17
Mar 188.47
Mar 189.08
Mar 189.08
Mar 189.38
Mar 189.38
Feb 1810.83
Feb 1810.29
Feb 189.86
Feb 1810.35
Jan 1810.35
Jan 1810.47
Jan 1810.89
Jan 1811.92
Dec 179.99
Dec 1711.8
Dec 1711.2
Dec 1712.1
Dec 1712.41
Nov 1710.89
Nov 1711.2
Nov 176.69
Nov 177.79
Oct 177.91
Oct 179.44
Oct 178.85
Oct 179.44
Sep 1710.62
Sep 1710.19
Sep 1710.9
Sep 1711.41
Sep 1710.14
Aug 1711.54
Aug 1711.61
Aug 177.59
Aug 179.63
Jul 1710.46
Jul 179.36
Jul 179.77
Jul 179.63
Jun 1710.46
Jun 1710.73
Adhera Therapeutics Inc
ATRX
Stockpicker

Video analysis: ATRX

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.